Related Experiment Video

Updated: Jun 16, 2026

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption
10:36

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption

Published on: June 20, 2017

The vascular hypothesis of Alzheimer's disease: bench to bedside and beyond

Jack C de la Torre1

  • 1Center for Alzheimer's Research, Banner Sun Health Research Institute, Sun City, AZ 85351, USA. jcdelatorre@comcast.net

Neuro-Degenerative Diseases
|February 23, 2010
PubMed

Insights

This study explores the vascular hypothesis of Alzheimer's disease (AD), identifying modifiable vascular risk factors like cardiovascular disease and carotid atherosclerosis. Early screening in middle-aged adults may prevent cognitive decline and reduce AD prevalence.

Area of Science:

  • Neurology
  • Cardiology
  • Gerontology

Background:

  • The vascular hypothesis of Alzheimer's disease (AD) links vascular factors to cognitive impairment.
  • Cardiovascular disease and carotid atherosclerosis are identified as key vascular risk factors for AD.
  • Chronic cerebral hypoperfusion due to vascular issues may contribute to AD pathology.

Purpose of the Study:

  • To propose and initiate a clinical study for early detection of vascular pathology in middle-aged individuals.
  • To identify modifiable cardiovascular and carotid artery conditions that may contribute to cognitive decline.
  • To assess the potential of early intervention strategies in preventing or delaying dementia onset.

Main Methods:

  • Screening of middle-aged, cognitively intact individuals.
  • Utilizing carotid artery ultrasound and echocardiography for pathological assessment.
  • Focusing on identifying progressive and modifiable heart and carotid artery conditions.

Main Results:

  • The study is designed to identify potentially progressive cardiovascular and carotid artery pathology.
  • The identified pathologies are considered modifiable with optimal medical treatment.
  • The effectiveness of this screening strategy in preventing cognitive impairment is to be determined.

Conclusions:

  • Early detection and management of vascular risk factors can potentially reduce Alzheimer's disease prevalence.
  • This approach may promote healthier cognitive and physical aging.
  • Widespread application could yield significant economic benefits by reducing dementia care costs.

More Related Videos

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction04:29

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction

Published on: May 17, 2024

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...